Both medications have the same active ingredient, an injectable originally meant for the management of Type-2 diabetics that also happens to be a potent appetite regulator
It activates GHRH receptors in the pituitary, prompting increased release of growth hormone (GH) and downstream production of IGF-1, which contributes to lipolysis, metabolic improvements, and fat redistribution
I, I think theres huge potential, across all forms of addiction, be it substance use and behavioral Jazmin Aguilera: Wow
Participant 3 tried unsuccessfully to manage her obesity through all medical means possible, from bariatric surgery, to medication, to behavioral therapy, and medication for dysregulated eating behavior and weight loss
However, the dye is chemically fragile and prone to form non-fluorescent aggregates in biological media
HX: Writing review & editing